2015 Q3 Form 10-Q Financial Statement

#000119312515378579 Filed on November 16, 2015

View on sec.gov

Income Statement

Concept 2015 Q3 2014 Q3
Revenue $12.29M $18.37M
YoY Change -33.1% 91.88%
Cost Of Revenue $10.90M $15.10M
YoY Change -27.81% 118.84%
Gross Profit $1.436M $3.266M
YoY Change -56.03% 22.64%
Gross Profit Margin 11.69% 17.78%
Selling, General & Admin $2.351M $2.226M
YoY Change 5.62% 1.37%
% of Gross Profit 163.72% 68.16%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $122.0K $25.00K
YoY Change 388.0% -82.76%
% of Gross Profit 8.5% 0.77%
Operating Expenses $2.351M $2.226M
YoY Change 5.62% 1.37%
Operating Profit -$1.015M $1.022M
YoY Change -199.32% 151.72%
Interest Expense $97.00K $0.00
YoY Change
% of Operating Profit 0.0%
Other Income/Expense, Net $28.00K $106.0K
YoY Change -73.58% 158.54%
Pretax Income -$987.0K $1.128M
YoY Change -187.5% 152.35%
Income Tax $36.00K $137.0K
% Of Pretax Income 12.15%
Net Earnings -$1.091M -$159.0K
YoY Change 586.16% -78.48%
Net Earnings / Revenue -8.88% -0.87%
Basic Earnings Per Share -$0.33 -$0.05
Diluted Earnings Per Share -$0.33 -$0.05
COMMON SHARES
Basic Shares Outstanding 3.284M shares 3.021M shares
Diluted Shares Outstanding 3.284M shares 3.021M shares

Balance Sheet

Concept 2015 Q3 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.800M $4.900M
YoY Change -63.27% 16.67%
Cash & Equivalents $1.761M $4.927M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $500.0K $300.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $2.300M $5.200M
YoY Change -55.77% -14.75%
LONG-TERM ASSETS
Property, Plant & Equipment $454.0K $260.0K
YoY Change 74.62% 4.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.500M $2.800M
YoY Change -10.71% -24.32%
Total Long-Term Assets $57.25M $49.22M
YoY Change 16.32% 9.25%
TOTAL ASSETS
Total Short-Term Assets $2.300M $5.200M
Total Long-Term Assets $57.25M $49.22M
Total Assets $59.55M $54.42M
YoY Change 9.43% 6.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.10M $11.70M
YoY Change -13.68% 34.48%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $46.90M $32.00M
YoY Change 46.56% 21.21%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $57.00M $43.80M
YoY Change 30.14% 24.08%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $57.00M $43.80M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $57.03M $43.80M
YoY Change 30.22% 23.94%
SHAREHOLDERS EQUITY
Retained Earnings -$174.1M -$167.8M
YoY Change 3.74% 2.81%
Common Stock $173.0M $171.2M
YoY Change 1.09% 0.3%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.644M $1.135M
YoY Change
Total Liabilities & Shareholders Equity $59.55M $54.42M
YoY Change 9.43% 6.39%

Cashflow Statement

Concept 2015 Q3 2014 Q3
OPERATING ACTIVITIES
Net Income -$1.091M -$159.0K
YoY Change 586.16% -78.48%
Depreciation, Depletion And Amortization $122.0K $25.00K
YoY Change 388.0% -82.76%
Cash From Operating Activities -$1.800M $4.100M
YoY Change -143.9% -146.59%
INVESTING ACTIVITIES
Capital Expenditures -$100.0K -$100.0K
YoY Change 0.0%
Acquisitions
YoY Change
Other Investing Activities -$200.0K -$300.0K
YoY Change -33.33%
Cash From Investing Activities -$200.0K -$400.0K
YoY Change -50.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.400M -3.500M
YoY Change -31.43% -318.75%
NET CHANGE
Cash From Operating Activities -1.800M 4.100M
Cash From Investing Activities -200.0K -400.0K
Cash From Financing Activities -2.400M -3.500M
Net Change In Cash -4.400M 200.0K
YoY Change -2300.0% -102.78%
FREE CASH FLOW
Cash From Operating Activities -$1.800M $4.100M
Capital Expenditures -$100.0K -$100.0K
Free Cash Flow -$1.700M $4.200M
YoY Change -140.48% -147.73%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
294000
CY2014Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
722000
CY2014Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
517000
CY2014Q3 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2014Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10620000
CY2014Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
4800000
CY2014Q3 us-gaap Assets
Assets
54418000
CY2014Q3 us-gaap Loans Receivable With Fixed Rates Of Interest1
LoansReceivableWithFixedRatesOfInterest1
180000
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4927000
CY2014Q3 chci Accrued Liability Settled Through Issuance Of Stock
AccruedLiabilitySettledThroughIssuanceOfStock
194000
CY2015Q3 us-gaap Variable Interest Entity Consolidated Carrying Amount Liabilities
VariableInterestEntityConsolidatedCarryingAmountLiabilities
16100000
CY2015Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
173044000
CY2015Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
19683000
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
-3644000
CY2015Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
9707000
CY2015Q3 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
17959000
CY2015Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
14128000
CY2015Q3 us-gaap Unsecured Debt
UnsecuredDebt
1724000
CY2015Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
3408000
CY2015Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-174060000
CY2015Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
262000
CY2015Q3 us-gaap Liabilities
Liabilities
57033000
CY2015Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
59552000
CY2015Q3 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2015Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2519000
CY2015Q3 us-gaap Notes Payable
NotesPayable
46926000
CY2015Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
3500000
CY2015Q3 us-gaap Minority Interest
MinorityInterest
6163000
CY2015Q3 us-gaap Secured Debt
SecuredDebt
27243000
CY2015Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
300000
CY2015Q3 us-gaap Variable Interest Entity Consolidated Carrying Amount Assets
VariableInterestEntityConsolidatedCarryingAmountAssets
24500000
CY2015Q3 us-gaap Assets
Assets
59552000
CY2015Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
50000000
CY2015Q3 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
49145000
CY2015Q3 us-gaap Escrow Deposit
EscrowDeposit
800000
CY2015Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
454000
CY2015Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
519000
CY2015Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
2200000
CY2015Q3 us-gaap Notes Receivable Gross
NotesReceivableGross
145000
CY2015Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
128000000
CY2015Q3 us-gaap Other Assets
OtherAssets
5185000
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1761000
CY2015Q3 chci Restricted Cash
RestrictedCash
2488000
CY2015Q3 chci Accrued Liability Settled Through Issuance Of Stock
AccruedLiabilitySettledThroughIssuanceOfStock
75000
CY2015Q3 chci Accounts Payable And Accrued Liabilities Current And Noncurrent Excluding Taxes Payable
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentExcludingTaxesPayable
10107000
CY2013Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
510000
CY2013Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
19059000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11895000
CY2014Q4 us-gaap Variable Interest Entity Consolidated Carrying Amount Liabilities
VariableInterestEntityConsolidatedCarryingAmountLiabilities
13500000
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
171639000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-2131000
CY2014Q4 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
15488000
CY2014Q4 us-gaap Unsecured Debt
UnsecuredDebt
2064000
CY2014Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
43000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-171218000
CY2014Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
492000
CY2014Q4 us-gaap Liabilities
Liabilities
54512000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
56367000
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1855000
CY2014Q4 us-gaap Notes Payable
NotesPayable
45931000
CY2014Q4 us-gaap Minority Interest
MinorityInterest
3986000
CY2014Q4 us-gaap Secured Debt
SecuredDebt
28379000
CY2014Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
500000
CY2014Q4 us-gaap Variable Interest Entity Consolidated Carrying Amount Assets
VariableInterestEntityConsolidatedCarryingAmountAssets
19500000
CY2014Q4 us-gaap Assets
Assets
56367000
CY2014Q4 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
40889000
CY2014Q4 us-gaap Escrow Deposit
EscrowDeposit
400000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
395000
CY2014Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
110000
CY2014Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1400000
CY2014Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
173000
CY2014Q4 us-gaap Other Assets
OtherAssets
5696000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7498000
CY2014Q4 chci Restricted Cash
RestrictedCash
1779000
CY2014Q4 chci Accounts Payable And Accrued Liabilities Current And Noncurrent Excluding Taxes Payable
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentExcludingTaxesPayable
8538000
CY2015Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.142857 pure
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.13
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
752000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
139000 shares
us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
-407000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3008000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3008000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.13
us-gaap Other Real Estate Period Increase Decrease
OtherRealEstatePeriodIncreaseDecrease
-1711000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
22154000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
90000
us-gaap Net Income Loss
NetIncomeLoss
-3402000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
62000
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
414000
us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
338000
us-gaap Profit Loss
ProfitLoss
-521000
us-gaap Other Real Estate Revenue
OtherRealEstateRevenue
408000
us-gaap Operating Income Loss
OperatingIncomeLoss
-426000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2254000
us-gaap Home Building Revenue
HomeBuildingRevenue
37713000
us-gaap Gross Profit
GrossProfit
7127000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
173000
us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
39000
us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
166000
us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
251000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
331000
us-gaap Real Estate Revenue Net
RealEstateRevenueNet
38121000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
9000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
434000
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
181000
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
8290000
us-gaap Interest Paid Net
InterestPaidNet
660000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
126000
us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
34000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-253000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
268000
us-gaap Share Based Compensation
ShareBasedCompensation
195000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
91000
us-gaap Equity Method Investment Summarized Financial Information Cost Of Sales
EquityMethodInvestmentSummarizedFinancialInformationCostOfSales
87000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1697000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
234000
dei Amendment Flag
AmendmentFlag
false
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-6968000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-602000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-7118000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4411000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
26000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
214000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5833000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-273000
us-gaap Real Estate Tax Expense
RealEstateTaxExpense
126000
us-gaap Home Building Costs
HomeBuildingCosts
30736000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
660000
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
8290000
us-gaap Interest Costs Incurred
InterestCostsIncurred
1699000
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
258000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
23528000
us-gaap Depreciation
Depreciation
73000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
73000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2881000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
23000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
20000
chci Interest And Real Estate Taxes Expensed As Component Of Cost Of Sales
InterestAndRealEstateTaxesExpensedAsComponentOfCostOfSales
592000
chci Ordinary Shares Withheld Under Share Based Compensation Value
OrdinarySharesWithheldUnderShareBasedCompensationValue
62000
chci Interest Expensed As Component Of Cost Of Sales
InterestExpensedAsComponentOfCostOfSales
466000
chci Interest And Real Estate Taxes Incurred And Capitalized
InterestAndRealEstateTaxesIncurredAndCapitalized
1872000
chci Real Estate Taxes Incurred And Capitalized
RealEstateTaxesIncurredAndCapitalized
173000
chci Real Estate Taxes Incurred And Expensed For Inactive Projects Net
RealEstateTaxesIncurredAndExpensedForInactiveProjectsNet
23000
chci Amounts Drawn Against Outstanding Letters Of Credit Or Performance Bonds
AmountsDrawnAgainstOutstandingLettersOfCreditOrPerformanceBonds
0
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.90
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-7352000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 Segment
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15000 shares
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001299969
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y2M12D
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
On September 25, 2015, to regain compliance with the NASDAQ listing requirement, the Company effected a 1-for-7 reverse stock split of its issued and outstanding shares of Class A common stock and Class B common stock and proportionately decreased the number of authorized shares of Common Stock. The reverse stock split was authorized by our Board of Directors and approved by our stockholders at the annual meeting of stockholders that was held on June 17, 2015. Every seven shares of issued and outstanding Class A common stock, including treasury shares, were exchanged into one share of the Company’s common stock. As a result of the reverse stock split, the number of authorized shares of Class A common stock was reduced from 77,266,500 shares to 11,038,071 shares and the number of authorized shares of Class B common stock was reduced from 2,733,500 shares to 390,500 shares. No fractional shares were issued in connection with the reverse stock split; instead, stockholders who otherwise would have received fractional shares received, in lieu of such fractional shares, an amount of cash based on the closing price of the Company’s common stock on the date of the reverse stock split.
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Registrant Name
EntityRegistrantName
Comstock Holding Companies, Inc.
us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
-370000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3166000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3166000 shares
dei Document Period End Date
DocumentPeriodEndDate
2015-09-30
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Use of Estimates</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> Our financial statements have been prepared in accordance with GAAP. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts for the reporting periods. We base these estimates and judgments on historical experience and on various other factors that we believe to be reasonable under the circumstances. We evaluate these estimates and judgements on an ongoing basis. Actual results may differ from those estimates under different assumptions or conditions.</p> </div>
dei Trading Symbol
TradingSymbol
CHCI
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.90
us-gaap Other Real Estate Period Increase Decrease
OtherRealEstatePeriodIncreaseDecrease
-8231000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
26258000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
168000
us-gaap Net Income Loss
NetIncomeLoss
2842000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
32000
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
140000
us-gaap Derivative Gain On Derivative
DerivativeGainOnDerivative
696000
us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
248000
us-gaap Profit Loss
ProfitLoss
-1965000
us-gaap Other Real Estate Revenue
OtherRealEstateRevenue
1001000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
79000
us-gaap Operating Income Loss
OperatingIncomeLoss
-2744000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-401000
us-gaap Home Building Revenue
HomeBuildingRevenue
34168000
us-gaap Gross Profit
GrossProfit
4780000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
802000
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
242000
us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
259000
us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
92000
us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
153000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
450000
us-gaap Real Estate Revenue Net
RealEstateRevenueNet
35169000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
409000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1198000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
319000
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
-27000
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
1150000
us-gaap Interest Paid Net
InterestPaidNet
245000
chci Interest And Real Estate Taxes Expensed As Component Of Cost Of Sales
InterestAndRealEstateTaxesExpensedAsComponentOfCostOfSales
1383000
us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
2450000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
77000
us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
9000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1942000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23000
us-gaap Share Based Compensation
ShareBasedCompensation
193000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
67000
us-gaap Equity Method Investment Summarized Financial Information Cost Of Sales
EquityMethodInvestmentSummarizedFinancialInformationCostOfSales
95000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1412000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
240000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
79000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5737000
us-gaap Restructuring Charges
RestructuringCharges
0
us-gaap Interest Expense
InterestExpense
418000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-591000
us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
414000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
2206000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-79000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2702000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
218000
us-gaap Notes Reduction
NotesReduction
543000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5686000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-43000
us-gaap Real Estate Tax Expense
RealEstateTaxExpense
156000
us-gaap Home Building Costs
HomeBuildingCosts
29933000
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
2450000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
694000
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1150000
us-gaap Interest Costs Incurred
InterestCostsIncurred
2514000
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
456000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
27367000
us-gaap Depreciation
Depreciation
109000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
327000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
877000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
426000
chci Number Of Debt Instrument
NumberOfDebtInstrument
3
chci Ordinary Shares Withheld Under Share Based Compensation Value
OrdinarySharesWithheldUnderShareBasedCompensationValue
32000
chci Maturity Date Of Note Receivable
MaturityDateOfNoteReceivable
2019-09-02
chci Period For Which Warranty Claims Expected To Arise Under Statutorily Period
PeriodForWhichWarrantyClaimsExpectedToAriseUnderStatutorilyPeriod
P2Y
chci Net Operating Loss Carry Forward Expiration Year Begin
NetOperatingLossCarryForwardExpirationYearBegin
2028
chci Separation Agreement Date
SeparationAgreementDate
2014-06-24
chci Interest Incurred And Expensed For Inactive Projects Net
InterestIncurredAndExpensedForInactiveProjectsNet
4000
chci Period For Which Warranty Claims Expected To Arise
PeriodForWhichWarrantyClaimsExpectedToArise
P1Y
chci Interest Expensed As Component Of Cost Of Sales
InterestExpensedAsComponentOfCostOfSales
1227000
chci Interest And Real Estate Taxes Incurred And Capitalized
InterestAndRealEstateTaxesIncurredAndCapitalized
2828000
chci Change In Ownership Of Shareholders In Specified Time
ChangeInOwnershipOfShareholdersInSpecifiedTime
P3Y
chci Real Estate Taxes Incurred And Capitalized
RealEstateTaxesIncurredAndCapitalized
314000
chci Debt Discount Amortization Period
DebtDiscountAmortizationPeriod
P3Y
chci Agreement Expiration Date
AgreementExpirationDate
2015-06-30
chci Interest Rate On Notes Receivable
InterestRateOnNotesReceivable
0.06 pure
chci Real Estate Taxes Incurred And Expensed For Inactive Projects Net
RealEstateTaxesIncurredAndExpensedForInactiveProjectsNet
8000
chci Increase In Class Common Stock Par Value In Connection With Issuance Of Stock Compensation
IncreaseInClassCommonStockParValueInConnectionWithIssuanceOfStockCompensation
1000
chci Amounts Drawn Against Outstanding Letters Of Credit Or Performance Bonds
AmountsDrawnAgainstOutstandingLettersOfCreditOrPerformanceBonds
0
CY2014 chci Number Of Debt Instrument
NumberOfDebtInstrument
3
CY2014Q2 us-gaap Health Care Organization Expenses Net
HealthCareOrganizationExpensesNet
14000
CY2014Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
131000
CY2014Q2 chci Number Of Semi Monthly Installment
NumberOfSemiMonthlyInstallment
36 Installment
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2014Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
102000 shares
CY2014Q3 us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
-275000
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3021000 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3021000 shares
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-159000
CY2014Q3 us-gaap Home Building Revenue
HomeBuildingRevenue
18225000
CY2014Q3 us-gaap Gross Profit
GrossProfit
3266000
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
106000
CY2014Q3 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
178000
CY2014Q3 us-gaap Real Estate Revenue Net
RealEstateRevenueNet
18367000
CY2014Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
89000
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1128000
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
137000
CY2014Q3 us-gaap Equity Method Investment Summarized Financial Information Cost Of Sales
EquityMethodInvestmentSummarizedFinancialInformationCostOfSales
28000
CY2014Q3 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
70000
CY2014Q3 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
206000
CY2014Q3 us-gaap Profit Loss
ProfitLoss
991000
CY2014Q3 us-gaap Other Real Estate Revenue
OtherRealEstateRevenue
142000
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1022000
CY2014Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
600000
CY2014Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
102000
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1626000
CY2014Q3 us-gaap Real Estate Tax Expense
RealEstateTaxExpense
70000
CY2014Q3 us-gaap Home Building Costs
HomeBuildingCosts
15021000
CY2014Q3 us-gaap Interest Costs Incurred
InterestCostsIncurred
619000
CY2014Q3 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
80000
CY2014Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
25000
CY2014Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1150000
CY2014Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
18000
CY2014Q3 chci Interest And Real Estate Taxes Expensed As Component Of Cost Of Sales
InterestAndRealEstateTaxesExpensedAsComponentOfCostOfSales
395000
CY2014Q3 chci Interest Expensed As Component Of Cost Of Sales
InterestExpensedAsComponentOfCostOfSales
325000
CY2014Q3 chci Interest And Real Estate Taxes Incurred And Capitalized
InterestAndRealEstateTaxesIncurredAndCapitalized
688000
CY2014Q3 chci Real Estate Taxes Incurred And Capitalized
RealEstateTaxesIncurredAndCapitalized
69000
CY2014Q3 chci Real Estate Taxes Incurred And Expensed For Inactive Projects Net
RealEstateTaxesIncurredAndExpensedForInactiveProjectsNet
18000
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
CY2015Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5000 shares
CY2015Q3 us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
-80000
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3284000 shares
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3284000 shares
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
1091000
CY2015Q3 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
48000
CY2015Q3 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
76000
CY2015Q3 us-gaap Profit Loss
ProfitLoss
-1023000
CY2015Q3 us-gaap Other Real Estate Revenue
OtherRealEstateRevenue
245000
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1015000
CY2015Q3 us-gaap Home Building Revenue
HomeBuildingRevenue
12043000
CY2015Q3 us-gaap Gross Profit
GrossProfit
1436000
CY2015Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
28000
CY2015Q3 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
46000
CY2015Q3 us-gaap Real Estate Revenue Net
RealEstateRevenueNet
12288000
CY2015Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
23000
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-987000
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
36000
CY2015Q3 us-gaap Equity Method Investment Summarized Financial Information Cost Of Sales
EquityMethodInvestmentSummarizedFinancialInformationCostOfSales
30000
CY2015Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
498000
CY2015Q3 us-gaap Interest Expense
InterestExpense
97000
CY2015Q3 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
97000
CY2015Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
66000
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1853000
CY2015Q3 us-gaap Real Estate Tax Expense
RealEstateTaxExpense
64000
CY2015Q3 us-gaap Home Building Costs
HomeBuildingCosts
10749000
CY2015Q3 us-gaap Interest Costs Incurred
InterestCostsIncurred
887000
CY2015Q3 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
103000
CY2015Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
122000
CY2015Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
68000
CY2015Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
100000
CY2015Q3 chci Interest And Real Estate Taxes Expensed As Component Of Cost Of Sales
InterestAndRealEstateTaxesExpensedAsComponentOfCostOfSales
535000
CY2015Q3 chci Interest Expensed As Component Of Cost Of Sales
InterestExpensedAsComponentOfCostOfSales
471000
CY2015Q3 chci Interest And Real Estate Taxes Incurred And Capitalized
InterestAndRealEstateTaxesIncurredAndCapitalized
1012000
CY2015Q3 chci Real Estate Taxes Incurred And Capitalized
RealEstateTaxesIncurredAndCapitalized
125000
CY2015Q3 chci Real Estate Taxes Incurred And Expensed For Inactive Projects Net
RealEstateTaxesIncurredAndExpensedForInactiveProjectsNet
3000

Files In Submission

Name View Source Status
0001193125-15-378579-index-headers.html Edgar Link pending
0001193125-15-378579-index.html Edgar Link pending
0001193125-15-378579.txt Edgar Link pending
0001193125-15-378579-xbrl.zip Edgar Link pending
chci-20150930.xml Edgar Link completed
chci-20150930.xsd Edgar Link pending
chci-20150930_cal.xml Edgar Link unprocessable
chci-20150930_def.xml Edgar Link unprocessable
chci-20150930_lab.xml Edgar Link unprocessable
chci-20150930_pre.xml Edgar Link unprocessable
d23268d10q.htm Edgar Link pending
d23268dex31.htm Edgar Link pending
d23268dex311.htm Edgar Link pending
d23268dex312.htm Edgar Link pending
d23268dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g23268img001.jpg Edgar Link pending
g23268img002.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending